Cite
HARVARD Citation
Parai, D. et al. (2021). Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection. Travel medicine and infectious disease. p. . [Online].